What is the equity of Spirox this year?
Spirox has equity of 2.52 B TWD this year.
Spirox Equity 2024
Spirox Equity
2.52 B TWD
Ticker
3055.TW
ISIN
TW0003055000
In 2024, Spirox's equity was 2.52 B TWD, a -9.43% increase from the 2.78 B TWD equity in the previous year.
Spirox Aktienanalyse
What does Spirox do?
The Spirox Corporation is a company that was founded in 2007 and is headquartered in Menlo Park, California. The company operates in the medical technology industry and specializes in the development of products for nasal breathing. The mission of Spirox is to help people who have difficulty breathing through their nose. The company has recognized that many people have difficulty breathing through their nose due to congestion or other issues. Breathing through the mouth, however, can lead to a range of health problems such as dry mouth, sleep apnea, and respiratory infections. Therefore, Spirox has set out to develop innovative solutions to facilitate nasal breathing. Spirox's products include both implantable and non-implantable solutions. The company has a small but effective product portfolio consisting of two products: the Latera Nasal Stent and the AeroForm Nasal Stent. The Latera Nasal Stent is used to permanently open the nasal passages and facilitate breathing. The placement of the stent is a minimally invasive procedure that is typically performed on an outpatient basis. The Latera Nasal Stent is inserted and secured in the nasal wings to allow for better airflow through the nostrils. The stent is made of polydioxanone (PDO), a biocompatible polymer fiber that is absorbed by the body. Spirox's second product, the AeroForm Nasal Stent, is a non-implantable nasal stent used for temporary relief of nasal breathing. The AeroForm is a soft stent made of a flexible polymer material. It is inserted into the nasal passages and forms a gentle expansion to facilitate nasal breathing. As a company, Spirox focuses on collaboration with specialists and clinics to ensure that their products have high success rates. The company has established a partnership with the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) to advance scientific research and development in the nasal breathing industry. Spirox is led by experienced executives from the medical technology industry. The CEO, Duke Rohlen, has over 20 years of experience in leading medical technology companies such as Inspire Medical Systems and CV Ingenuity. The board team also includes Elektra Papadopoulos as Chair of the Board, who has worked at Hologic and Boston Scientific, among others. Although Spirox is a relatively small company, it has already received several awards. In 2017, the company was awarded the Red Herring Top 100 North America Award, which recognizes companies that are leading in the innovation industry. Overall, Spirox is an emerging company in the medical technology industry that offers innovative solutions to facilitate nasal breathing. Through collaboration with doctors and clinics and a focus on scientific research, the company aims to improve the success and effectiveness of its products. Spirox ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Spirox's Equity
Spirox's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Spirox's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Spirox's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Spirox's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Spirox’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Spirox stock
What was the equity of Spirox compared to the previous year?
The equity of Spirox has increased/decreased by -9.43% decreased compared to the previous year.
What impact does a high equity have on investors of Spirox?
A high equity is advantageous for investors of Spirox as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Spirox?
A low equity can be a risk for investors of Spirox, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Spirox affect the company?
An increase in equity of Spirox can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Spirox affect the company?
A reduction in equity of Spirox can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Spirox?
Some factors that can affect the equity of Spirox include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Spirox so important for investors?
The equity of Spirox is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Spirox take to change the equity?
To change equity, Spirox can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Spirox pay?
Over the past 12 months, Spirox paid a dividend of 1 TWD . This corresponds to a dividend yield of about 1.48 %. For the coming 12 months, Spirox is expected to pay a dividend of 0.87 TWD.
What is the dividend yield of Spirox?
The current dividend yield of Spirox is 1.48 %.
When does Spirox pay dividends?
Spirox pays a quarterly dividend. This is distributed in the months of October, August, August, August.
How secure is the dividend of Spirox?
Spirox paid dividends every year for the past 0 years.
What is the dividend of Spirox?
For the upcoming 12 months, dividends amounting to 0.87 TWD are expected. This corresponds to a dividend yield of 1.29 %.
In which sector is Spirox located?
Spirox is assigned to the 'Information technology' sector.
Wann musste ich die Aktien von Spirox kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Spirox from 8/6/2024 amounting to 1.011 TWD, you needed to have the stock in your portfolio before the ex-date on 7/5/2024.
When did Spirox pay the last dividend?
The last dividend was paid out on 8/6/2024.
What was the dividend of Spirox in the year 2023?
In the year 2023, Spirox distributed 0.2 TWD as dividends.
In which currency does Spirox pay out the dividend?
The dividends of Spirox are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Spirox
Our stock analysis for Spirox Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spirox Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.